Krystal Biotech (FRA:4KB) Change In Inventory: €-4.4 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:4KB Krystal Biotech Inc FRA:4KB
59 GF Score
Price €292.50
GF Value €259.92
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Krystal Biotech Change In Inventory?

Krystal Biotech FRA:4KB -2.99% 59 Change In Inventory is €-4.4 Mil as of Mar. 2026. GuruFocus rates FRA:4KB with a GF Score™ of 59/100 and a GF Value™ of €259.92 (Fairly Valued). The stock has 6 warning signs investors should review.

Krystal Biotech's change in inventory for the quarter that ended in Mar. 2026 was €-0.2 Mil. It means Krystal Biotech's inventory increased by €0.2 Mil from Dec. 2025 to Mar. 2026 .

Krystal Biotech's change in inventory for the fiscal year that ended in Dec. 2025 was €-5.4 Mil. It means Krystal Biotech's inventory increased by €5.4 Mil from Dec. 2024 to Dec. 2025 .

Krystal Biotech's Total Inventories for the quarter that ended in Mar. 2026 was €36.9 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Krystal Biotech's Days Inventory for the quarter that ended in Mar. 2026 was 596.00.

Inventory Turnover measures how fast the company turns over its inventory within a year. Krystal Biotech's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.15.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Krystal Biotech's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.35.

Krystal Biotech  (FRA:4KB) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Krystal Biotech's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=35.7275/5.47*365 / 4
=596.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Krystal Biotech's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=5.47 / 35.7275
=0.15

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Krystal Biotech's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=35.7275 / 100.649
=0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krystal Biotech Change In Inventory Related Terms

Krystal Biotech Change In Inventory Historical Data

* Premium members only.

The historical data trend for Krystal Biotech's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krystal Biotech Change In Inventory Chart

Krystal Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -4.10 -11.37 -5.37

Krystal Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.29 0.76 -4.02 -0.90 -0.21
FRA:4KB
59GF Score
Krystal Biotech Inc FRA:4KB
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krystal Biotech Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-4.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of €-4.4 Mil mean?
Krystal Biotech (FRA:4KB) has a Change In Inventory of €-4.4 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Krystal Biotech and its competitors.
Is Krystal Biotech's Change In Inventory too high?
Krystal Biotech's current Change In Inventory is €-4.4 Mil. Overall, Krystal Biotech has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Krystal Biotech's Change In Inventory compare to TECH and SMMT?
Krystal Biotech's Change In Inventory of €-4.4 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Krystal Biotech and its competitors. Krystal Biotech's current Change In Inventory is €-4.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krystal Biotech stock overvalued right now?
Based on GuruFocus' analysis, Krystal Biotech (FRA:4KB) is currently considered Fairly Valued. The stock's GF Value™ is €259.92, compared to a current price of €292.50 — trading 12.5% above its estimated fair value. The current Change In Inventory is €-4.4 Mil. Krystal Biotech's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Krystal Biotech (FRA:4KB), the current Change In Inventory is €-4.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krystal Biotech (FRA:4KB) Overvalued in 2026?

Based on GuruFocus' analysis, Krystal Biotech stock appears to be overvalued. The current stock price of €292.50 is trading 12.5% above its estimated GF Value™ of €259.92. GuruFocus considers Krystal Biotech to be Fairly Valued.

Key valuation signals for FRA:4KB:

  • Change In Inventory: €-4.4 Mil
  • GF Value™: €259.92 vs. price of €292.50 (12.5% above fair value)
  • GF Score™: 59/100 with 6 warning signs

No single metric tells the full story. See the FRA:4KB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Krystal Biotech Business Description

Address 2100 Wharton Street, Suite 701, Pittsburgh, PA, USA, 15203
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
59GF Score

Get the complete analysis for FRA:4KB

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€292.50
Price
€259.92
GF Value